Simultaneously decoding the transcriptome, epigenome and 3D genome within a single cell

The origin of many diseases begins at the cellular level and involves multiple molecular interactions. However, previous methods have struggled to accurately observe changes in individual cells.
Las Vegas Sun

LabVantage Solutions Introduces LabVantage CORTEX, Advancing Its LIMS Platform for AI-Driven Laboratory Operations

LabVantage CORTEX is built to support the growing demand for intelligent, automated laboratory environments across industries, including pharma and biotech, food and beverage, oil and gas, forensics, ...

Drug Farm Announces FDA Acceptance of DF-003 into Rare Disease Evidence Principles Process for ROSAH Syndrome

Drug Farm today announced that the U.S. Food and Drug Administration (U.S. Food and Drug Administration, FDA) has accepted DF-003, the company's investigational therapy for ROSAH syndrome, into the ...
EurekAlert!

Rice-led research to develop first regenerative therapy for lymphedema receives up to $18.2M federal award

A team of researchers led by Rice bioengineer Omid Veiseh has been awarded up to $18.2 million in funding from the Advanced Research Projects Agency for Health to develop a first-of-its-kind ...

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Shared 12-month clinical results of ongoing UP421 type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted ...
Precision Medicine Online

Can Rare Disease Drugmakers Trust FDA's Promises of Flexibility Amid String of Rejections?

While the US Food and Drug Administration touts new regulatory flexibility for rare disease drugs, recent rejections of ...
TASS Russian News Agency

Government begins preparing biotech development framework in Russia — PM Mishustin

The prime minister instructed his deputy Dmitry Chernyshenko to keep the issue of biotech development in Russia under personal supervision ...
TMCnet

VERAXA Biotech Shareholders Approve Merger and Issuance of New Shares to Voyager Acquisition Corp.

The merger will be carried out by means of an absorption merger. Veraxa Biotech Holding AG, as the acquiring company, will take over VERAXA as the transferring company and simultaneously change its ...

Physician tells Senate: ‘Something has gone seriously wrong in the FDA'

A Senate hearing probed whether the Food and Drug Administration's process for approving rare-disease therapies is ...
TMCnet

Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform

Genenta Science S.p.A. (Nasdaq: GNTA) in transformation to Saentra Forge (Nasdaq: SAEN), a strategic industrial consolidator focused on biotech, defense, aerospace, and national-security-related ...

Puma Biotechnology, Inc. (PBYI) Q4 2025 Earnings Call Transcript

Puma Biotechnology, Inc. ( PBYI) Q4 2025 Earnings Call February 26, 2026 4:30 PM EST Good morning -- good afternoon, ladies and gentlemen. My name is Sherry, and I will be your conference call ...
manilatimes

PCI Biotech initiates a process to evaluate the opportunity for a structured wind-up process

Oslo (Norway), 29 January 2026 - PCI Biotech (OSE: PCIB) refers to its latest announcement of 8 January 2026 regarding the discontinuation of all R&D operations and the continued exploration of ...